Replies to post #44001 on Pluristem Therapeutics Inc (PSTI)

[jaime9_2000]

The last 2 pages of the 10Q are very concerning. The outlook for the short and near term don't look good. Revenues for the next 12 months will be less than costs. And, saving the worst for last, they may initiate a reverse stock split in order to meet Nasdaq compliance.